Today’s Headlines: NSAIDs, Ovarian Cancer and Preservatives in Cheese

FDA reconsiders heart safety of common pain pills: The Food and Drug Administration (FDA) is taking “a second look this week at the heart safety of pain medications used by millions of Americans to treat arthritis and other everyday aches and pains.” Health experts will analyze the most recent research on the safety of NSAIDs to determine whether naproxen, which is found in Aleve and other generic pain medications, may have a “lower risk of heart attack and stroke than rival medications like ibuprofen.” Based on the latest data from a large review, the panel will vote on whether naproxen is actually safer for the heart and should be relabeled to reflect this. “The FDA is not required to follow the group’s advice, though it often does.” (ABC News)

Daily aspirin may reduce ovarian cancer risk: Women who take a daily low-dose aspirin (under 100 mg) may reduce their ovarian cancer risk by 20%, according to new research from the National Institutes of Health. Prior studies on the topic had yielded inconclusive results. The data came from 12 large studies and “included 7,776 women who had ovarian cancer and 11,843 women who did not.” However, researchers said further study was required and said patients should “follow the guidance of their doctor for aspirin use.” (Fox News)  

Kraft Singles cut out the artificial preservatives: “Kraft Cheese will no longer use artificial preservatives in its Kraft Singles full-fat American and White American cheese.” Though the FDA says sorbic acid, the artificial preservative in the cheeses, is safe for consumption, consumer demand for more natural foods prompted the company to make the change. A natural preservative called natamycin will replace sorbic acid. “The new cheese will be on grocery shelves within the next few weeks and will have a red circle on its packaging to indicate it is free of artificial preservatives.” In the future, Kraft may make a similar change in its other products. (TIME)